Click for best price
Brain Cancer Targeted Drug Market Size, Share 2023
A?brain tumor?is a mass or growth of abnormal cells in your brain. Many different types of?brain tumors?exist.?
This report contains market size and forecasts of Brain Cancer Targeted Drug in Global, including the following market information:
Global Brain Cancer Targeted Drug Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Brain Cancer Targeted Drug market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Belzutifan (Welireg) Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Brain Cancer Targeted Drug include Merck & Co., Roche and Novartis, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Brain Cancer Targeted Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brain Cancer Targeted Drug Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Brain Cancer Targeted Drug Market Segment Percentages, by Type, 2022 (%)
Belzutifan (Welireg)
Bevacizumab (Avastin)
Everolimus (Afinitor)
Global Brain Cancer Targeted Drug Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Brain Cancer Targeted Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Brain Cancer Targeted Drug Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Brain Cancer Targeted Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Brain Cancer Targeted Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Brain Cancer Targeted Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co.
Roche
Novartis
| Report Attributes |
Report Details |
| Report Title |
Brain Cancer Targeted Drug Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Brain Cancer Targeted Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Brain Cancer Targeted Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Brain Cancer Targeted Drug Overall Market Size
2.1 Global Brain Cancer Targeted Drug Market Size: 2022 VS 2030
2.2 Global Brain Cancer Targeted Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Brain Cancer Targeted Drug Players in Global Market
3.2 Top Global Brain Cancer Targeted Drug Companies Ranked by Revenue
3.3 Global Brain Cancer Targeted Drug Revenue by Companies
3.4 Top 3 and Top 5 Brain Cancer Targeted Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Brain Cancer Targeted Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Brain Cancer Targeted Drug Players in Global Market
3.6.1 List of Global Tier 1 Brain Cancer Targeted Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Brain Cancer Targeted Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Brain Cancer Targeted Drug Market Size Markets, 2022 & 2030
4.1.2 Belzutifan (Welireg)
4.1.3 Bevacizumab (Avastin)
4.1.4 Everolimus (Afinitor)
4.2 By Type - Global Brain Cancer Targeted Drug Revenue & Forecasts
4.2.1 By Type - Global Brain Cancer Targeted Drug Revenue, 2018-2023
4.2.2 By Type - Global Brain Cancer Targeted Drug Revenue, 2023-2030
4.2.3 By Type - Global Brain Cancer Targeted Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Brain Cancer Targeted Drug Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Brain Cancer Targeted Drug Revenue & Forecasts
5.2.1 By Application - Global Brain Cancer Targeted Drug Revenue, 2018-2023
5.2.2 By Application - Global Brain Cancer Targeted Drug Revenue, 2023-2030
5.2.3 By Application - Global Brain Cancer Targeted Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Brain Cancer Targeted Drug Market Size, 2022 & 2030
6.2 By Region - Global Brain Cancer Targeted Drug Revenue & Forecasts
6.2.1 By Region - Global Brain Cancer Targeted Drug Revenue, 2018-2023
6.2.2 By Region - Global Brain Cancer Targeted Drug Revenue, 2023-2030
6.2.3 By Region - Global Brain Cancer Targeted Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Brain Cancer Targeted Drug Revenue, 2018-2030
6.3.2 US Brain Cancer Targeted Drug Market Size, 2018-2030
6.3.3 Canada Brain Cancer Targeted Drug Market Size, 2018-2030
6.3.4 Mexico Brain Cancer Targeted Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Brain Cancer Targeted Drug Revenue, 2018-2030
6.4.2 Germany Brain Cancer Targeted Drug Market Size, 2018-2030
6.4.3 France Brain Cancer Targeted Drug Market Size, 2018-2030
6.4.4 U.K. Brain Cancer Targeted Drug Market Size, 2018-2030
6.4.5 Italy Brain Cancer Targeted Drug Market Size, 2018-2030
6.4.6 Russia Brain Cancer Targeted Drug Market Size, 2018-2030
6.4.7 Nordic Countries Brain Cancer Targeted Drug Market Size, 2018-2030
6.4.8 Benelux Brain Cancer Targeted Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Brain Cancer Targeted Drug Revenue, 2018-2030
6.5.2 China Brain Cancer Targeted Drug Market Size, 2018-2030
6.5.3 Japan Brain Cancer Targeted Drug Market Size, 2018-2030
6.5.4 South Korea Brain Cancer Targeted Drug Market Size, 2018-2030
6.5.5 Southeast Asia Brain Cancer Targeted Drug Market Size, 2018-2030
6.5.6 India Brain Cancer Targeted Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Brain Cancer Targeted Drug Revenue, 2018-2030
6.6.2 Brazil Brain Cancer Targeted Drug Market Size, 2018-2030
6.6.3 Argentina Brain Cancer Targeted Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Brain Cancer Targeted Drug Revenue, 2018-2030
6.7.2 Turkey Brain Cancer Targeted Drug Market Size, 2018-2030
6.7.3 Israel Brain Cancer Targeted Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Brain Cancer Targeted Drug Market Size, 2018-2030
6.7.5 UAE Brain Cancer Targeted Drug Market Size, 2018-2030
7 Players Profiles
7.1 Merck & Co.
7.1.1 Merck & Co. Corporate Summary
7.1.2 Merck & Co. Business Overview
7.1.3 Merck & Co. Brain Cancer Targeted Drug Major Product Offerings
7.1.4 Merck & Co. Brain Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.1.5 Merck & Co. Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Brain Cancer Targeted Drug Major Product Offerings
7.2.4 Roche Brain Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.2.5 Roche Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Brain Cancer Targeted Drug Major Product Offerings
7.3.4 Novartis Brain Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Brain Cancer Targeted Drug Market Opportunities & Trends in Global Market
Table 2. Brain Cancer Targeted Drug Market Drivers in Global Market
Table 3. Brain Cancer Targeted Drug Market Restraints in Global Market
Table 4. Key Players of Brain Cancer Targeted Drug in Global Market
Table 5. Top Brain Cancer Targeted Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Brain Cancer Targeted Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Brain Cancer Targeted Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Brain Cancer Targeted Drug Product Type
Table 9. List of Global Tier 1 Brain Cancer Targeted Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brain Cancer Targeted Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Brain Cancer Targeted Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Brain Cancer Targeted Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Brain Cancer Targeted Drug Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Brain Cancer Targeted Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Brain Cancer Targeted Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Brain Cancer Targeted Drug Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Brain Cancer Targeted Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Brain Cancer Targeted Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Brain Cancer Targeted Drug Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Brain Cancer Targeted Drug Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Brain Cancer Targeted Drug Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Brain Cancer Targeted Drug Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Brain Cancer Targeted Drug Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Brain Cancer Targeted Drug Revenue, (US$, Mn), 2023-2030
Table 30. Merck & Co. Corporate Summary
Table 31. Merck & Co. Brain Cancer Targeted Drug Product Offerings
Table 32. Merck & Co. Brain Cancer Targeted Drug Revenue (US$, Mn), (2018-2023)
Table 33. Roche Corporate Summary
Table 34. Roche Brain Cancer Targeted Drug Product Offerings
Table 35. Roche Brain Cancer Targeted Drug Revenue (US$, Mn), (2018-2023)
Table 36. Novartis Corporate Summary
Table 37. Novartis Brain Cancer Targeted Drug Product Offerings
Table 38. Novartis Brain Cancer Targeted Drug Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Brain Cancer Targeted Drug Segment by Type in 2022
Figure 2. Brain Cancer Targeted Drug Segment by Application in 2022
Figure 3. Global Brain Cancer Targeted Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Brain Cancer Targeted Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Brain Cancer Targeted Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Brain Cancer Targeted Drug Revenue in 2022
Figure 8. By Type - Global Brain Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Brain Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 10. By Region - Global Brain Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 11. By Country - North America Brain Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 12. US Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Brain Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 16. Germany Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 17. France Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Brain Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 24. China Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 28. India Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Brain Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 30. Brazil Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Brain Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 33. Turkey Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Brain Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 37. Merck & Co. Brain Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Roche Brain Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Novartis Brain Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
